Floatz logo

Alpha-Interferon

Gestational Trophoblastic Neoplasm

Cancer Treatment Centers of AmericaPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Gestational Trophoblastic Neoplasm cohort.

Asset / SponsorPhaseRating
Amifostine
Gynecologic Oncology Group
Phase 3B
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 2B
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Fred Hutchinson Cancer Center
Phase 2B
MOXIFLOXACIN
OHSU Knight Cancer Institute
Phase 3B
Zofran
Fred Hutchinson Cancer Center
Phase 2B

View all 25 →

Same molecule, other indications

Alpha-Interferon is also rated in:

cutaneous melanomaDormant
BBB
Indicative ·
74 / 100
View asset →
renal cell carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
kidney cancerDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →